Abstract
Among the adenosine A1 allosteric enhancers reported so far, compound (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)- methanone 1 (named T-62) has shown biological properties similar to those of PD 81,723, the reference A1 allosteric enhancer and it has been more fully pharmacologically investigated. The preparation of the radiolabelled form of compound 1 and its characterization by saturation binding experiments are reported. These studies allowed us to demonstrate for the first time the existence of a specific, allosteric site on the A1 receptor. © 2005 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 1402-1404 |
| Journal | Bioorganic & medicinal chemistry letters |
| Volume | 16 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Mar 2006 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver